answersdiva-ga,
Bingo! It took a fair amount of digging, but I finally got it:
===============
Med Ad News
Beyond boundaries: as the generic market grows, so does Novartis'
Sandoz; other pharmaceutical companies also are realizing the benefits
of generic units in the business mix.
1 July 2005
Company name 2004 sales ($ in millions)
Sandoz 5,100 *
Teva 4,800
Merck Generics 1,986
Ivax 1,837
Watson 1,641
Mylan 1,374
Alpharma 1,340
Barr 1,309
Ranbaxy 1,178
Andrx 1,145
===============
This was the status at the end of 2004.
Of course, things change rapidly in this business, and it appears that
Teva is back on top as of very recently:
===============
Chemist & Druggist
July 30, 2005
Teva reclaims top spot
.....Teva Pharmaceuticals has reclaimed pole position as the world's
biggest generics manufacturer after its pounds 4.2 billion acquisition
of US firm IVAX Corp...The Israeli company has regained the top spot
lost to Swiss drugs manufacturer Novartis following its purchase of
Eon laboratories and Hexal earlier this year...
===============
I trust these data fully answer your question.
However, please don't rate this answer until you have everything you
need. If there's anything more I can do for you, just let me know by
posting a Request for Clarification, and I'm at your service.
Cheers,
pafalafa-ga
search strategy -- Searched Google and a variety of newspaper,
magazine and specialty (medical) databases for [ teva sandoz watson
alpharma barr ] |